Results for Thrombotic Microangiopathy

Share:
1 - 6 of 6
Benjamin L. Laskin, MD, MS
Benjamin L. Laskin

Dr. Laskin's research focuses on the conduct of clinical investigations and translational studies designed to target mechanisms to prevent, treat, or slow the progression of chronic kidney disease in immunosuppressed patients, including children receiving a bone marrow or kidney transplant.

E-mail:
laskinb [at] chop.edu
Jason L. Freedman, MD, MSCE
Jason L. Freedman

Dr. Freedman has a particular interest in epidemiologic and translational research within pediatric supportive oncology. He aims to advance the understanding and treatment of symptoms, infections, and organ toxicities in pediatric cancer and hematopoietic stem cell transplant patients.

E-mail:
freedmanj [at] chop.edu

In the News: CHOP at ASGCT, Treatment for Friedreich’s Ataxia, New Nephrology Chief

Published on
Jul 8, 2022
in Cornerstone Blog
In the News
This week’s In the News features ASGCT meeting highlights, our new Nephrology Chief, and more.

In The News: March of Dimes Prize, Immunotherapy, CHOP CARES, MIS-C, PCORI Grant

Published on
Feb 4, 2022
in Cornerstone Blog
In the News
Learn about novel findings neuroblastoma, MIS-C, and more in this week's roundup of research news.

SARS-CoV-2 Infections Regardless of Severity Linked to Blood Vessel Damage in Children

Published on
Dec 16, 2020
in Cornerstone Blog
SARS-CoV-2 Infections Linked to Blood Vessel Damage
SARS-CoV-2 Infections, even those with minimal or no symptoms, are linked to blood vessel damage in children.

CHOP Researchers Elucidate Clinical, Immune-related Features of MIS-C

Published on
Jul 30, 2020
in Cornerstone Blog
CHOP Researchers Identify Features of MIS-C
Researchers at CHOP are studying the features and causes of multisystem inflammatory syndrome in children.
1 - 6 of 6